Development of a Nanoemulgel for the Topical Application of Mupirocin
Pharmaceutics · 26.09.2023 · 15 (10) · 2387
DOI: 10.3390/pharmaceutics15102387 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmaceutics, online erschienen am 26.09.2023. Verfasst von Bahjat Alhasso und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, School of Applied Sciences, University of Huddersfield, Huddersfield HD1 3DH, UK. Die Arbeit wurde bisher 55-mal zitiert (Crossref) und nennt 76 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Mupirocin (MUP) is an effective topical antibiotic with poor skin permeability; however, its skin permeability can be improved by a nanoemulsion formulation based on eucalyptus oil or eucalyptol. Despite this improvement, the nanoemulsion has limitations, such as low viscosity, low spreadability, and poor retention on the skin. To overcome these limitations, the aim of this study was to develop a nanoemulgel formulation that would enhance its rheological behaviour and physicochemical properties. The MUP nanoemulgel was prepared by incorporating a preprepared MUP nanoemulsion into Carbopol gel at a concentration of 0.75% in a 1:1 ratio. The nanoemulgel formulations were characterised and evaluated for their physicochemical and mechanical strength properties, rheological behaviour, and in vitro skin permeation and deposition, as well as antibacterial studies. Both nanoemulgels exhibited stability at temperatures of 4 and 25 °C for a period of 3 months. They had a smooth, homogenous, and consistent appearance and displayed non-Newtonian pseudoplastic behaviour, with differences in their viscosity and spreadability. However, both nanoemulgels exhibited lower skin permeability compared to the marketed control. The local accumulation efficiency of MUP from nanoemulgel after 8 h was significantly higher than that of the control, although there was no significant difference after 24 h. Micro-CT scan imaging allowed visualisation of these findings and interpretation of the deposited drug spots within the layers of treated skin. While there were no significant differences in the antibacterial activities between the nanoemulgels and the control, the nanoemulgels demonstrated superiority over the control due to their lower content of MUP. These findings support the potential use of the nanoemulgel for targeting skin lesions where high skin deposition and low permeability are required, such as in the case of topical antibacterial agents.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pharmacy, School of Applied Sciences, University of Huddersfield, Huddersfield HD1 3DH, UK.
- Department of Biological and Geographical Sciences, University of Huddersfield, Huddersfield HD1 3DH, UK
- Institute of Skin Integrity and Infection Prevention, University of Huddersfield, Huddersfield HD1 3DH, UK.
ORCID-Profile: Bahjat Alhasso, Muhammad Usman Ghori, Simon P Rout, Barbara R Conway
Zitieren
APA
Alhasso, B., Ghori, M. U., Rout, S. P., & Conway, B. R. (2023). Development of a Nanoemulgel for the Topical Application of Mupirocin. Pharmaceutics, 15(10), 2387. https://doi.org/10.3390/pharmaceutics15102387
Vancouver
Alhasso B, Ghori MU, Rout SP, Conway BR. Development of a Nanoemulgel for the Topical Application of Mupirocin. Pharmaceutics. 2023;15(10):2387. doi:10.3390/pharmaceutics15102387
BibTeX
@article{Alhasso2023,
author = {Alhasso, Bahjat and Ghori, Muhammad Usman and Rout, Simon P and Conway, Barbara R},
title = {Development of a Nanoemulgel for the Topical Application of Mupirocin},
journal = {Pharmaceutics},
year = {2023},
volume = {15},
number = {10},
pages = {2387},
doi = {10.3390/pharmaceutics15102387}
}
EUVIMED